Glycemic control during TB treatment among Filipinos [TB0101]

·  High TB Incidence in the Philippines: The Philippines has one of the highest TB incidences globally (539/100,000).

·  Diabetes Prevalence: In 2020, 6.5% of Filipino adults were estimated to have diabetes mellitus (DM), as reported by the International Diabetes Federation.

·  Impact of Poor Glycemic Control: Poor long-term glycemic control, measured by HbA1c, is associated with an increased risk of TB, severe clinical presentations, and poor TB treatment outcomes.

·  Factors Affecting Glycemic Control: Individual health status, disease management practices, and the health system all influence glycemic control in DM patients.

·  Central Obesity as a Diabetes Risk Factor: Central obesity, common in Asian populations, predicts diabetes and is associated with hyperglycemia and poor glycemic control at TB treatment onset, which can negatively impact TB outcomes.

·  TB and Transient Hyperglycemia: TB-related inflammation and insulin resistance may cause transient hyperglycemia, resolving with effective TB treatment and potentially confounding earlier study findings.

·  Glycemic Control Over DM Presence: The degree of glycemic control may be more critical to TB outcomes than simply having or not having DM.

·  DM Diagnosis Timing and Blood Glucose Control: Patients diagnosed with DM before starting TB treatment are more likely to have uncontrolled blood glucose levels during treatment than those diagnosed with DM at treatment start.

·  Transient Hyperglycemia and Overdiagnosis Risk: One-third of those initially identified as new DM cases may have only transient hyperglycemia, suggesting that DM screening in TB programs should confirm diagnoses outside the acute treatment phase.

·  Central Obesity and HbA1c Levels: Among DM patients, those without central obesity had higher HbA1c levels than centrally obese individuals if diagnosed before TB treatment. Conversely, those diagnosed at treatment start had higher HbA1c levels if centrally obese.

·  DM and TB Advanced Disease Stage: For TB-DM patients without central obesity, higher HbA1c levels may indicate advanced disease and metabolic disruption. This could reflect severe disease stages in TB or both TB and DM.

·  Research and Multi-site Collaboration: Exclusions of patients with fewer HbA1c results and small outcome categories may introduce bias in studies. Future studies require larger sample sizes (over 1,000 TB-DM patients) to assess the impact of poor glycemic control on TB outcomes, likely necessitating multi-site collaboration.

Source: Oliveira Hashiguchi, L., Ferrer, J.P., Suzuki, S., Faguer, B.N., Solon, J.A., Castro, M.C., et al. (2024). Glycemic control during TB treatment among Filipinos: The Starting Anti-Tuberculosis Treatment Cohort Study. PLOS Global Public Health, 4(5), e0003156. 

 

Comments

Popular posts from this blog

Health status and treatment outcome of TB with DM cases, Gujarat [TB0104]

The potential association between metabolic disorders and pulmonary TB [TB0109]

The definition of tuberculosis infection based on the spectrum of TB disease [TB0112]